#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Noonan syndrome Advanced systemic mastocytosis Hypoxic-ischaemic encephalopathy Synovial sarcoma recurrent Neurofibroma Uveitis Endometrial adenocarcinoma Basal cell naevus syndrome Sickle cell disease Erythema Univentricular heart Mantle cell lymphoma stage II Laryngeal squamous cell carcinoma Hypersomnia Lymphoma More trials…

    Learn about Rare Diseases

    Factor IX deficiency – Diagnostics Rosai-Dorfman syndrome Gastrointestinal stromal tumour – Trials in Disease Biotinidase deficiency – Trials in Disease Burkitt’s lymphoma – Trials in Disease Paraneoplastic neurological syndrome – Basic Information Encephalitis autoimmune – Life with Disease Marginal zone lymphoma – Life with Disease Pemphigoid Familial haemophagocytic lymphohistiocytosis – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Sulfonamides, Urea Derivatives Rigosertib Sodium Indacaterol Lixisenatide Abacavir Sulfate PROMESTRIENE Naxitamab Oxitriptan Brexpiprazole CAL101 Nilutamide Givinostat TX000045 Nefopam Setmelanotide Bimatoprost Azd2693 Sodium Tamibarotene Famotidine Dornase Alfa More therapies…

    Learn about Your Condition

    Angiosarcoma metastatic Type V hyperlipidaemia Incontinence Non-obstructive cardiomyopathy Lymphatic malformation Hypoglycaemia Radius fracture Sickle cell anaemia Liposarcoma Aortic valve stenosis Open angle glaucoma Thermal burn Univentricular heart Elderly Torticollis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Netherton’s syndrome

  • A Study of BCX17725 Safety and Effects in Healthy People and Patients with Netherton Syndrome

    Recruiting

    1 1 1
    France Germany The Netherlands
  • Study on the Safety and Effectiveness of SXR1096 Cream for Patients with Netherton Syndrome

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Netherton’s syndrome
    Investigated Drugs:
    • Sxr1096
    Austria France Germany Sweden
  • Study to Evaluate the Effectiveness of Spesolimab in Treating Patients with Netherton Syndrome

    Not recruiting

    4 1
    Investigated Diseases:
    • Netherton’s syndrome
    Investigated Drugs:
    • Spesolimab
    Austria Belgium Bulgaria Czechia Finland France +5
  • Study on the Safety of DS-2325a for Patients with Netherton Syndrome

    Not recruiting

    1 1 1
    Investigated Diseases:
    • Netherton’s syndrome
    Investigated Drugs:
    • Ds-2325A
    • Sodium Chloride Solution 0.9%
    France

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.


European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!